US-manufactured vs imported peptides: what the label doesn't tell you
Nearly every peptide supplier in the United States describes itself as "US-based." Far fewer synthesize and lyophilize their product in the United States. The difference matters for quality, for traceability, and for what you can put in a compliance file.
Three supply models
- US-manufactured: solid-phase synthesis, purification and lyophilization done in a US facility, tested by a US lab, with the manufacturer named in the qualification packet.
- US-tested import: bulk peptide imported, then re-tested and vialed or relabeled in the US. Can be high quality; the manufacturing site is usually not disclosed.
- Relabeled import: finished vials imported and relabeled with a US brand. Traceability ends at the importer.
Why it matters
Traceability: a recall or an inspector's question about origin has an answer only if the manufacturing site is documented. Consistency: a single US manufacturer produces the same material lot after lot; an importer sources from whoever has stock. Lead time: domestic manufacturing can allocate inventory to your forecast; importers wait on containers and customs.
Questions that get a straight answer
- Where was this lot synthesized and lyophilized? Name the facility.
- Can I have the supplier qualification packet with site information?
- Are the CoA and the retained sample from the same lot I'm receiving?
- Do you hold retained samples, and for how long?
If the answers are vague, the supplier is a reseller. That's not disqualifying on its own, but you should price and document it accordingly. Our manufacturing and testing are described on the quality page, and we'll put the answers to those four questions in writing on request.